arch42

EN_01446596_7146

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

special instructions

GERMANY OUT Internet +100%

caption

27 November 2019, Rhineland-Palatinate, Mainz: Ugur Sahin, CEO BioNTech, gesticulated during the interview. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa

headline arch42

created date 2019-11-27

credit Andreas Arnold/AFP/East News

source AFP

byline Andreas Arnold

original transmission reference 043_dpa-pa_191213-99-123106_dpai

weight 5,62MB

size 51cm x 33cm by 300dpi

keywords - Show

2019, 27, A, AND, ANDREAS, APPROACH, ARNOLD, BIONTECH, BIOTECHNOLOGY, CANCER, CEO, COMPANY, DEVELOPING, DISEASES, DPA, DURING, FOCUSED, FOR, GESTICULATED, HEALTH, INTERVIEW, IS, MAINZ, MANUFACTURING, MEDICINE, NOVEMBER, OF, ON, OTHER, PATIENT-SPECIFIC, RESEARCH, RHINELAND-PALATINATE, SAHIN, SCIENCE, SERIOUS, THE, TREATMENT, UGUR,